SLQT vs. RDZN, GOCO, FANH, EHTH, FPH, VCV, RMT, FMNB, CAC, and GLRE
Should you be buying SelectQuote stock or one of its competitors? The main competitors of SelectQuote include Roadzen (RDZN), GoHealth (GOCO), Fanhua (FANH), eHealth (EHTH), Five Point (FPH), Invesco California Value Municipal Income Trust (VCV), Royce Micro-Cap Trust (RMT), Farmers National Banc (FMNB), Camden National (CAC), and Greenlight Capital Re (GLRE). These companies are all part of the "finance" sector.
Roadzen (NASDAQ:RDZN) and SelectQuote (NYSE:SLQT) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, community ranking, risk, analyst recommendations and media sentiment.
24.7% of Roadzen shares are owned by institutional investors. Comparatively, 34.6% of SelectQuote shares are owned by institutional investors. 10.4% of SelectQuote shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
SelectQuote received 29 more outperform votes than Roadzen when rated by MarketBeat users. However, 100.00% of users gave Roadzen an outperform vote while only 46.15% of users gave SelectQuote an outperform vote.
Roadzen has higher earnings, but lower revenue than SelectQuote.
Roadzen has a net margin of 0.00% compared to Roadzen's net margin of -4.12%. SelectQuote's return on equity of 0.00% beat Roadzen's return on equity.
In the previous week, Roadzen had 7 more articles in the media than SelectQuote. MarketBeat recorded 7 mentions for Roadzen and 0 mentions for SelectQuote. Roadzen's average media sentiment score of 0.88 beat SelectQuote's score of 0.76 indicating that SelectQuote is being referred to more favorably in the news media.
Roadzen currently has a consensus target price of $10.00, indicating a potential upside of 167.38%. SelectQuote has a consensus target price of $4.00, indicating a potential upside of 29.45%. Given SelectQuote's stronger consensus rating and higher possible upside, research analysts plainly believe Roadzen is more favorable than SelectQuote.
Roadzen has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500. Comparatively, SelectQuote has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.
Summary
Roadzen beats SelectQuote on 8 of the 13 factors compared between the two stocks.
Get SelectQuote News Delivered to You Automatically
Sign up to receive the latest news and ratings for SLQT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SLQT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
SelectQuote Competitors List
Related Companies and Tools
